TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors

被引:910
作者
Voegel, JJ
Heine, MJS
Zechel, C
Chambon, P
Gronemeyer, H
机构
[1] Inst. Genet. Biol. Molec. et Cell., CNRS/INSERM/ULP/College de France, CU de Strasbourg, 67404 Illkrich Cedex
关键词
ligand binding domain; retinoid receptors; steroid receptors; transcriptional coactivator; transcriptional squelching;
D O I
10.1002/j.1460-2075.1996.tb00736.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear receptors (NRs) act as ligand-inducible transcription factors which regulate the expression of target genes upon binding to cognate response elements. The ligand-dependent activity of the NR activation function AF-2 is believed to be mediated to the transcription machinery through transcriptional mediators/intermediary factors (TIFs), We report here the cloning of the 160 kDa human nuclear protein TIF2, which exhibits all properties expected for a mediator of AF-2: (i) it interacts in vivo with NRs in an agonist-dependent manner; (ii) it binds directly to the ligand-binding domains (LBDs) of NRs in an agonist- and AF-2-integrity-dependent manner in vitro; (iii) it harbours an autonomous transcriptional activation function; (iv) it relieves nuclear receptor autosquelching; and (v) it enhances the activity of some nuclear receptor AF-2s when overexpressed in mammalian cells, TIF2 exhibits partial sequence homology with the recently isolated steroid receptor coactivator SRC-1, indicating the existence of a novel gene family of nuclear receptor transcriptional mediators.
引用
收藏
页码:3667 / 3675
页数:9
相关论文
共 41 条
[1]  
Ausubel FM., 1993, Current Protocols in Molecular Biology
[2]   CHARACTERIZATION OF THE LIGAND-DEPENDENT TRANSACTIVATION DOMAIN OF THYROID-HORMONE RECEPTOR [J].
BARETTINO, D ;
RUIZ, MDMV ;
STUNNENBERG, HG .
EMBO JOURNAL, 1994, 13 (13) :3039-3049
[3]   Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1 [J].
Baur, EV ;
Zechel, C ;
Heery, D ;
Heine, MJS ;
Garnier, JM ;
Vivat, V ;
LeDouarin, B ;
Gronemeyer, H ;
Chambon, P ;
Losson, R .
EMBO JOURNAL, 1996, 15 (01) :110-124
[4]   STEROID-HORMONE RECEPTORS - MANY ACTORS IN SEARCH OF A PLOT [J].
BEATO, M ;
HERRLICH, P ;
SCHUTZ, G .
CELL, 1995, 83 (06) :851-857
[5]   ROLE OF THE 2 ACTIVATING DOMAINS OF THE ESTROGEN-RECEPTOR IN THE CELL-TYPE AND PROMOTER-CONTEXT DEPENDENT AGONISTIC ACTIVITY OF THE ANTIESTROGEN 4-HYDROXYTAMOXIFEN [J].
BERRY, M ;
METZGER, D ;
CHAMBON, P .
EMBO JOURNAL, 1990, 9 (09) :2811-2818
[6]   THE CONTRIBUTION OF THE N-TERMINAL AND C-TERMINAL REGIONS OF STEROID-RECEPTORS TO ACTIVATION OF TRANSCRIPTION IS BOTH RECEPTOR AND CELL-SPECIFIC [J].
BOCQUEL, MT ;
KUMAR, V ;
STRICKER, C ;
CHAMBON, P ;
GRONEMEYER, H .
NUCLEIC ACIDS RESEARCH, 1989, 17 (07) :2581-2595
[7]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[8]   INTERACTION OF PROTEINS WITH TRANSCRIPTIONALLY ACTIVE ESTROGEN-RECEPTORS [J].
CAVAILLES, V ;
DAUVOIS, S ;
DANIELIAN, PS ;
PARKER, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :10009-10013
[9]   NUCLEAR FACTOR RIP140 MODULATES TRANSCRIPTIONAL ACTIVATION BY THE ESTROGEN-RECEPTOR [J].
CAVAILLES, V ;
DAUVOIS, S ;
LHORSET, F ;
LOPEZ, G ;
HOARE, S ;
KUSHNER, PJ ;
PARKER, MG .
EMBO JOURNAL, 1995, 14 (15) :3741-3751
[10]   RAR-SPECIFIC AGONIST/ANTAGONISTS WHICH DISSOCIATE TRANSACTIVATION AND AP1 TRANSREPRESSION INHIBIT ANCHORAGE-INDEPENDENT CELL-PROLIFERATION [J].
CHEN, JY ;
PENCO, S ;
OSTROWSKI, J ;
BALAGUER, P ;
PONS, M ;
STARRETT, JE ;
RECZEK, P ;
CHAMBON, P ;
GRONEMEYER, H .
EMBO JOURNAL, 1995, 14 (06) :1187-1197